Table 1—

Baseline characteristics

Rosiglitazone + insulinPlacebo + insulin
n2525
Age (years)43.7 ± 13.341.1 ± 9.2
Sex (M/F)16/918/7
Ethnic group (n)22 Caucasian, 3 African American23 Caucasian, 1 African American, 1 Hispanic
Duration of diabetes (years)20.7 ± 13.318.1 ± 9.3
Waist-to-hip ratio0.91 ± 0.070.93 ± 0.06
Fasting C-peptide (ng/ml)0.3 ± 0.30.3 ± 0.3
  • Data are means ± SD or n.